JW Therapeutics closes USD100m Series B financing round

2020-06-12
|
Isiah Liu

JW Therapeutics announced the completion of a US$100 million Series B round of financing, the investment was co-led by CPE and Mirae Asset, jointed by CR-CP Life Science Fund and Oriza Holdings, as well as existing investors including Loyal Valley Capital, Temasek, Sequoia Capital China, ARCH Venture Partners, Juno Therapeutics, a Bristol Myers Squibb company, and WuXi AppTec.


JW Therapeutics will use the proceeds to further advance the clinical trials of its lead product JWCAR029 (a CAR-T cell product targeting CD19), further build-out a pipeline, and gear up to establish commercialization capabilities to support product launch.


James Li, Co-Founder and CEO of JW Therapeutics, commented: “We are very pleased to welcome our new investors and, by working together, we hope to accelerate our product development and serve Chinese patients.”


RELATED ARTICLES

Xbed Xi Hotel receives RMB100 million in financing
2020-11-18
|
Tourism , PEVC

Memoray completes tens of millions of yuan in Series B financing
2020-11-18
|
PEVC , Medical care

Sier Education closes multi-mln-dollar Pre-A led by Qiming Venture Partners
2020-10-26
|
Education , PEVC

Eugenlight Technologies closes Series A of RMB tens of millions
2020-09-13
|
PEVC , Semiconductor , Electroinic

BPassword closes angel round led by Eagle Fund
2020-09-13
|
PEVC , Blockchain

PackGene Biotech closes multimillion-yuan Series B led by Cathay Capital
2020-08-14
|
PEVC , Biotech , Biology

Brite Semiconductor closes RMB350m Series D
2020-08-09
|
Semiconductor , Chip , IoT , Integrated circuit

Shengli Financial Software closes RMB100m Series B+ led by Sequoia Capital China
2020-08-06
|
PEVC , Fintech , Software

Tongcheng Shenghuo merges with FamilyOne, secures multimillion-dollar Series C+ round
2020-08-06
|
PEVC , Retail , e-commerce , Fresh food

Infinovo Medical closes multimillion-yuan Series B round led by Vertex
2020-07-29
|
Medical device , PEVC
China SDG